scientific article published on 26 March 2014

AttributesValues
rdf:type
description
  • videnskabelig artikel (da)
  • article científic (ca)
  • articolo scientifico (it)
  • artigo científico (pt)
  • bilimsel makale (tr)
  • vedecký článok (sk)
  • vetenskaplig artikel (sv)
  • vědecký článek (cs)
  • wetenschappelijk artikel (nl)
  • wissenschaftlicher Artikel (de)
  • научни чланак (sr)
  • article scientifique (fr)
  • artículu científicu espublizáu en 2014 (ast)
  • наукова стаття, опублікована в березні 2014 (uk)
  • scientific article published on 26 March 2014 (en)
  • مقالة علمية نشرت في 26 مارس 2014 (ar)
publication date
publication date
language of work or name
language of work or name
cites work
cites work
author name string
author name string
  • Jay W Mason
  • Albert Dietz
  • Erin O'Boyle
  • Thomas E Moon
rdfs:label
  • A randomized, placebo-controlled, four-period crossover, definitive QT study of the effects of APF530 exposure, high-dose intravenous granisetron, and moxifloxacin on QTc prolongation (en)
  • A randomized, placebo-controlled, four-period crossover, definitive QT study of the effects of APF530 exposure, high-dose intravenous granisetron, and moxifloxacin on QTc prolongation (nl)
  • A randomized, placebo-controlled, four-period crossover, definitive QT study of the effects of APF530 exposure, high-dose intravenous granisetron, and moxifloxacin on QTc prolongation (ast)
skos:prefLabel
  • A randomized, placebo-controlled, four-period crossover, definitive QT study of the effects of APF530 exposure, high-dose intravenous granisetron, and moxifloxacin on QTc prolongation (en)
  • A randomized, placebo-controlled, four-period crossover, definitive QT study of the effects of APF530 exposure, high-dose intravenous granisetron, and moxifloxacin on QTc prolongation (nl)
  • A randomized, placebo-controlled, four-period crossover, definitive QT study of the effects of APF530 exposure, high-dose intravenous granisetron, and moxifloxacin on QTc prolongation (ast)
name
  • A randomized, placebo-controlled, four-period crossover, definitive QT study of the effects of APF530 exposure, high-dose intravenous granisetron, and moxifloxacin on QTc prolongation (en)
  • A randomized, placebo-controlled, four-period crossover, definitive QT study of the effects of APF530 exposure, high-dose intravenous granisetron, and moxifloxacin on QTc prolongation (nl)
  • A randomized, placebo-controlled, four-period crossover, definitive QT study of the effects of APF530 exposure, high-dose intravenous granisetron, and moxifloxacin on QTc prolongation (ast)
title
title
  • A randomized, placebo-controlled, four-period crossover, definitive QT study of the effects of APF530 exposure, high-dose intravenous granisetron, and moxifloxacin on QTc prolongation (en)
page(s)
page(s)
  • 181-190
instance of
instance of
main subject
main subject
PubMed ID
PubMed ID
PubMed ID
  • 24741326
published in
published in
volume
volume
  • 6
DOI
DOI
DOI
  • 10.2147/CMAR.S58071
copyright license
copyright status
copyright license
copyright status
PMCID
PMCID
  • 3970917
is about of
is cites work of
is cites work of
Faceted Search & Find service v1.16.117 as of May 05 2024


Alternative Linked Data Documents: ODE     Content Formats:   [cxml] [csv]     RDF   [text] [turtle] [ld+json] [rdf+json] [rdf+xml]     ODATA   [atom+xml] [odata+json]     Microdata   [microdata+json] [html]    About   
This material is Open Knowledge   W3C Semantic Web Technology [RDF Data] Valid XHTML + RDFa
OpenLink Virtuoso version 07.20.3239 as of May 5 2024, on Linux (x86_64-centos_6-linux-gnu), Single-Server Edition (378 GB total memory, 172 GB memory in use)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2024 OpenLink Software